ACTRN12612000692831尚未招募1 期
Effect of a Sulforaphane-Yielding Encapsulated Product compared with Placebo on Arterial Stiffness and other Biochemical Markers in Type 2 Diabetics aged 18-45 years.
niversity of Queensland0 个研究点目标入组 82 人开始时间: 2012年6月28日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 82
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 45 Years（—）
- 性别
- All
入选标准
- •Medically-diagnosed with Type 2 diabetes without disease complications. Medication schedule must have been stable for at least 6 months and is not expected to change within the next 6 months. Must be able to attend the research clinic on 4 separate occasions over the 6 month-period of the trial. Must be prepared to take 6 plant-based capsules daily and refrain from eating cruciferous vegetables
排除标准
- •Evident diabetic complications such as retinopathy, neuropathy and nephropathy. Those whose diabetic condition requires regular insulin. Smokers and those using recreational drugs. Males conusming more than 4 alcoholic drinks and females consuing more than 2 alcoholic drinks daily. Those with BMI > 30 or < 20.
研究者
相似试验
招募中
2 期
The effect of sulforaphane on depression in women with PCOSSeverity of depression.Polycystic ovarian syndromeE28.2IRCT20090117001556N144Tehran University of Medical Sciences50
已完成
不适用
Effect of hyper protect capsule on viability of probiotics that reach to the large intestines/A(healthy adults)JPRN-UMIN000038798Morishita Jintan Co., Ltd.12
已完成
不适用
A comparison of conventional high-flux versus a novel Helixone dialysis membrane on oxidative stress in stable haemodialysis patients.HaemodialysisRenal and Urogenital - Kidney diseaseACTRN12610000427077Fresenius Medical Care Southeast Asia60
已完成
不适用
Study on the absorption of sulforaphaneHealthy adultsJPRN-UMIN000023134Innovation Division, Kagome Co., Ltd.20
已完成
不适用
Study on the absorption of sulforaphane after ingesting vegetable materialsHealthy adultsJPRN-UMIN000039385Innovation Division, Kagome Co., Ltd.15